RxDoctor Payments Data

Krishan Gupta, MD

Psychiatry · Jackson, MSNPI 1598769176

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $19,620 of the $25,678 with a category attached, or 76.4%. 25 manufacturers reported payments, led by AbbVie at 44.9% of the total. Reporting peaked in 2021 at $14,704 and has fallen 94.5% since, to $816 in 2025. Among psychiatry clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$25,678in general payments, 2019–2025

Across 379 payments — averaging $67.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$12K
  • Supernus Pharmaceuticals, Inc.$9K
  • Otsuka America Pharmaceutical, Inc.$826
  • Vanda Pharmaceuticals Inc.$718
  • Teva Pharmaceuticals USA, Inc.$552
  • Tris Pharma Inc$480
  • plus $2K from 19 others

What the payments were for

  • Speaking & faculty fees$19,62076%
  • Travel & lodging$310%
  • Food & beverage$5,70522%
  • Education$3221%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,678 in reported general payments places this provider in the 95th percentile of 219 psychiatry providers in Mississippi.

See all psychiatry providers in Mississippi

Medicare billing

Part B allowed, 2024
$9,787
Medicare patients
32
Services billed
129

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine42$1,683
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine22$1,112
Clonazepam86$661
Duloxetine Hcl40$495
Zolpidem Tartrate50$485
Quetiapine Fumarate52$468
Oxcarbazepine13$397
Hydroxyzine Pamoate30$319
Gabapentin22$297
Olanzapine15$257
Trazodone Hcl88$239
Paroxetine Hcl17$221
Mirtazapine25$203
Bupropion XlBupropion Hcl21$193
Benztropine Mesylate13$185

Paid to pharmacies, not to this prescriber.

Other psychiatry in Jackson

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →